CoChat

Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases

Open access
Mauvais-Jarvis, Franck · 2012 · Diabetes

The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.

Abstract

Over the past two decades, the female hormone 17β-estradiol (estrogen) has emerged as an important contributor to energy homeostasis in both males and females. Early clinical evidence involved the observation that men lacking estrogen synthesis secondary to mutations in aromatase—the enzyme that converts androgen to estrogen—or men harboring estrogen resistance secondary to mutation of the estrogen receptor (ER)α, develop visceral obesity, insulin resistance, and/or glucose intolerance (1,2). As an experimental confirmation, it was observed that elimination of the aromatase or ERα genes in male and female mice produced the same metabolic syndrome as in humans (3,4). Thus, it is reasonable to assume that although men have lower circulating estrogen concentrations than premenopausal women, aromatization of circulating androgen to estrogen in target metabolic tissues equilibrates cellular estrogen concentrations, and ER activation is critical in both sexes in promoting fuel homeostasis (5). This is consistent with the paradigm that estrogen functions as a circulating hormone in premenopausal women. Conversely, in men and in postmenopausal women—in whom estrogen concentrations are low—estradiol does not function as a hormone; instead, it is synthesized in extragonadal sites such as breast, brain, bone, and fat where it acts locally as a paracrine or intracrine factor (6). Thus, in men and in postmenopausal women, the driver of estrogen action is not circulating estrogens; rather, it depends on estrogen biosynthesis from a circulating source of androgenic precursors such as testosterone. A logical consequence …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db12-0357

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Intracrinology of estrogen in adipose tissue. In premenopausal women, estrogen (E2) functions as a circulating hormone. Conversely, in men and in postmenopausal women, E2 is locally synthesized from androgenic precursors such as testosterone (T), androstendione (4A), or dehydroepiandrosterone (DHEA) in extragonadal sites such as breast, brain, bone, and fat. Cellular estrogenic output depends on 1) the ER signaling and sensitivity, 2) the activity of enzymes such as aromatase involved in the biosynthesis of E2 from androgenic precursors, and 3) the inactivation of E2 in E2 sulfate (E2-S) by the EST.
FIG. 1. Intracrinology of estrogen in adipose tissue. In premenopausal women, estrogen (E2) functions as a circulating hormone. Conversely, in men and in postmenopausal women, E2 is locally synthesized from androgenic precursors such as testosterone (T), androstendione (4A), or dehydroepiandrosterone (DHEA) in extragonadal sites such as breast, brain, bone, and fat. Cellular estrogenic output depends on 1) the ER signaling and sensitivity, 2) the activity of enzymes such as aromatase involved in the biosynthesis of E2 from androgenic precursors, and 3) the inactivation of E2 in E2 sulfate (E2-S) by the EST.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 18

Metadata

Authors
Mauvais-Jarvis, F.
Affiliations
Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Comprehensive Center on Obesity, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Venue
Diabetes
Published
2012-05-14
Volume
61
Issue
6
Pages
1353-1354
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2118759932
Cited by
18
References
22
Citations by year
2025: 1 · 2023: 1 · 2021: 2 · 2020: 1 · 2018: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 5
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • March of Dimes Foundation
  • American Heart Association (11IRG5570010)
  • National Institutes of Health (HD044405)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK074970)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
estrogen sulfotransferase, estradiol, aromatase, estrogen receptor alpha, energy homeostasis, visceral obesity, insulin resistance, impaired glucose tolerance, metabolic syndrome
MeSH terms
Animals, Diabetes Mellitus, Type 2, Female, Insulin Resistance, Liver, Male, Sulfotransferases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases. https://app.cochat.ai/papers/10.2337/db12-0357
The paper
Mauvais-Jarvis, F. (2012). Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases. Diabetes. https://doi.org/10.2337/db12-0357

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.